|
Amryt Pharma
topical gene therapy product candidate based on highly branched poly-β-amino esters (hpbaes) Topical Gene Therapy Product Candidate Based On Highly Branched Poly β Amino Esters (Hpbaes), supplied by Amryt Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/topical gene therapy product candidate based on highly branched poly-β-amino esters (hpbaes)/product/Amryt Pharma Average 90 stars, based on 1 article reviews
topical gene therapy product candidate based on highly branched poly-β-amino esters (hpbaes) - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
Cartagenia Inc
hpo-based candidate gene prioritization Hpo Based Candidate Gene Prioritization, supplied by Cartagenia Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hpo-based candidate gene prioritization/product/Cartagenia Inc Average 90 stars, based on 1 article reviews
hpo-based candidate gene prioritization - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
Tenaya Therapeutics
aav9 capsid  Aav9 Capsid, supplied by Tenaya Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/aav9 capsid/product/Tenaya Therapeutics Average 86 stars, based on 1 article reviews
aav9 capsid - by Bioz Stars,
2026-06
86/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Frontiers in Medicine
Article Title: High rate of seroeligibility among MYBPC3 -associated hypertrophic cardiomyopathy patients for TN-201, an adeno-associated virus serotype 9 MYBPC3 gene therapy
doi: 10.3389/fmed.2025.1635586
Figure Lengend Snippet: Distribution of neutralizing antibodies to AAV9.
Article Snippet: Assay plates were coated with
Techniques:
Journal: Frontiers in Medicine
Article Title: High rate of seroeligibility among MYBPC3 -associated hypertrophic cardiomyopathy patients for TN-201, an adeno-associated virus serotype 9 MYBPC3 gene therapy
doi: 10.3389/fmed.2025.1635586
Figure Lengend Snippet: Distribution of total antibodies to AAV9.
Article Snippet: Assay plates were coated with
Techniques: